Carlo de Notaristefani
Director/Board Member bei Medarex, Inc.
Profil
Carlo de Notaristefani ist Mitglied des Vorstands von Medarex, Inc. Zuvor war er Executive Vice President-Global Operations bei Teva Pharmaceutical Industries Ltd. und President-Technical Operations bei Bristol Myers Squibb Co. sowie Senior Vice President-Global Finishing Solids bei Aventis Pharmaceuticals, Inc. Er erhielt einen Doktortitel von der Universit degli Studi di Napoli Federico II.
Aktive Positionen von Carlo de Notaristefani
| Unternehmen | Position | Beginn |
|---|---|---|
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Director/Board Member | 02.09.2009 |
Ehemalige bekannte Positionen von Carlo de Notaristefani
| Unternehmen | Position | Ende |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Chief Operating Officer | 02.10.2019 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.07.2011 |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
Ausbildung von Carlo de Notaristefani
| Università degli Studi di Napoli Federico II | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Commercial Services |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
